Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103 Wenhua Road, Shenyang 110016 China.
Department of Pharmacology, School of Life Sciences and Bio-pharmaceuticals, Shenyang Pharmaceutical University, No. 103 Wenhua Road, Shenyang 110016 China.
Acta Biomater. 2017 Oct 15;62:157-166. doi: 10.1016/j.actbio.2017.08.025. Epub 2017 Aug 18.
The high affinity of positively charged nanoparticles to biological interfaces makes them easily taken up by tumor cells but limits their tumor permeation due to non-specific electrostatic interactions. In this study, polyion complex coated nanoparticles with different charge reversal profiles were developed to study the influence of charge reversal profile on tumor penetration. The system was constructed by polyion complex coating using micelles composed of poly (lysine)-b-polycaprolactone (PLys-b-PCL) as the cationic core and poly (glutamic acid)-g- methoxyl poly (ethylene glycol) (PGlu-g-mPEG) as the anionic coating material. Manipulation of charge reversal profile was achieved by controlling the polymer chain entanglement and electrostatic interaction in the polyion complex layer through glutaraldehyde-induced shell-crosslinking. The delayed charge reversal nanoparticles (CTCL30) could maintain negatively charged in pH 6.5 PBS for at least 2h and exhibit pH-responsive cytotoxicity and cellular uptake in an extended time scale. Compared with a faster charge reversal counterpart (CTCL70) with similar pharmacokinetic profile, CTCL30 showed deeper penetration, higher in vivo tumor cell uptake and stronger antitumor activity in vivo (tumor inhibition rate: 72.3% vs 60.2%, compared with CTCL70). These results indicate that the delayed charge reversal strategy could improve therapeutic effect via facilitating tumor penetration.
Here, the high tumor penetration capability of PEG-coated nanoparticles and the high cellular uptake of cationic nanoparticles were combined by a delayed charge reversal drug delivery system. This drug delivery system was composed of a drug-loading cationic inner core and a polyion complex coating. Manipulation of charge reversal profile was realized by varying the crosslinking degree of the shell of the cationic inner core, through which changed the strength of the polyion complex layer. Nanoparticles with delayed charge reversal profile exhibited improved tumor penetration, in vivo tumor cell uptake and in vivo tumor growth inhibition effect although they have similar pharmacokinetic and biodistribution behaviors with their instant charge reversal counterpart.
带正电荷的纳米粒子与生物界面的高亲和力使它们很容易被肿瘤细胞吸收,但由于非特异性静电相互作用,限制了它们在肿瘤中的渗透。在这项研究中,开发了具有不同电荷反转特性的聚离子复合物包覆的纳米粒子,以研究电荷反转特性对肿瘤渗透的影响。该系统通过聚离子复合物涂层构建,使用由聚(赖氨酸)-b-聚己内酯(PLys-b-PCL)组成的胶束作为阳离子核,聚(谷氨酸)-g-甲氧基聚(乙二醇)(PGlu-g-mPEG)作为阴离子包覆材料。通过戊二醛诱导的壳交联来控制聚离子复合物层中的聚合物链缠结和静电相互作用,从而实现电荷反转特性的操控。延迟电荷反转纳米粒子(CTCL30)在 pH6.5PBS 中至少 2h 内保持负电荷,并在延长的时间范围内表现出 pH 响应性细胞毒性和细胞摄取。与具有相似药代动力学特征的更快电荷反转对应物(CTCL70)相比,CTCL30 显示出更深的渗透、更高的体内肿瘤细胞摄取和更强的体内抗肿瘤活性(肿瘤抑制率:72.3%比 60.2%,与 CTCL70 相比)。这些结果表明,延迟电荷反转策略可以通过促进肿瘤渗透来提高治疗效果。
在这里,通过延迟电荷反转药物递送系统将 PEG 包覆纳米粒子的高肿瘤穿透能力和阳离子纳米粒子的高细胞摄取能力结合在一起。该药物递送系统由载药阳离子内核和聚离子复合物涂层组成。通过改变阳离子内核壳的交联程度来实现电荷反转特性的操控,从而改变聚离子复合物层的强度。具有延迟电荷反转特性的纳米粒子表现出改善的肿瘤穿透、体内肿瘤细胞摄取和体内肿瘤生长抑制作用,尽管它们与即时电荷反转对应物具有相似的药代动力学和生物分布行为。